PCRX vs DVAX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
PCRX
DVAX
Investment Advisor Scores
DVAX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | DVAX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 9.009 | 29.2398 | PCRX |
| PEG Ratio | 11.2121 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 5.0% | 17.7% | DVAX |
| Earnings Growth | -30.0% | 69.3% | DVAX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 54.7/100 | 55.1/100 | DVAX |
| Profit Margin | 0.7% | -13.1% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PCRX
MarkupPrice above SMA50, rising 50-day trend (3.3% over 20 days), RSI 61
DVAX
MarkupPrice above SMA50, rising 50-day trend (15.8% over 20 days), RSI 75
Fundamentals Snapshot
| Metric | PCRX | DVAX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.2 | 47.0 |
| Trailing P/E | 207.5 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.2% |
| Gross Margin | 0.8% | 0.6% |
| Operating Margin | 0.0% | 0.2% |
| EPS | 0.13 | -0.37 |
| Dividend Yield | — | — |